What is the recommended hydrocortisone dosing regimen for a child in shock with suspected adrenal insufficiency in India?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hydrocortisone Dosing for Pediatric Shock with Suspected Adrenal Insufficiency in India

For a child in shock with suspected adrenal insufficiency, immediately administer a weight-based stress dose of intravenous or intramuscular hydrocortisone: 25 mg for children <15 kg (0-2 years), 50 mg for 15-25 kg (2-6 years), or 100 mg for >25 kg (>6 years), followed by aggressive fluid resuscitation with 10-20 mL/kg boluses of 0.9% sodium chloride. 1

Initial Emergency Management

The cornerstone of treating adrenal crisis in children is rapid glucocorticoid administration combined with aggressive volume resuscitation. The 2021 Endocrine guidelines provide clear, weight-based dosing that should be followed immediately upon suspicion of adrenal crisis:

Stress Dose Hydrocortisone (First-Line)

  • Children <15 kg (0-2 years): 25 mg IV or IM
  • Children 15-25 kg (2-6 years): 50 mg IV or IM
  • Children >25 kg (>6 years): 100 mg IV or IM

This represents 50-100 mg/m² body surface area and can be repeated if necessary based on clinical response 1. The guideline emphasizes that if peripheral venous access cannot be obtained quickly, do not delay—give the dose intramuscularly immediately 2.

Concurrent Fluid Resuscitation

If the patient is in shock, simultaneously administer 10-20 mL/kg boluses of 0.9% sodium chloride IV and repeat as necessary until hemodynamic stability is achieved 1. This addresses the hypovolemia that commonly accompanies adrenal crisis.

Maintenance Therapy After Initial Stabilization

Once the initial stress dose is given and the patient begins to stabilize, transition to maintenance hydrocortisone:

Administer 50-100 mg/m²/24 hours divided every 6 hours IV, or alternatively as a continuous IV infusion at 2-3 mg/m²/hour 1. The continuous infusion may provide more stable cortisol levels in critically ill children.

Critical Supportive Measures

  • Start maintenance fluids: 0.9% sodium chloride with 5% glucose to address ongoing deficit and dehydration
  • Monitor blood glucose hourly: If <3.5 mmol/L (63 mg/dL), give 2-5 mL/kg of 10% glucose 1
  • Check electrolytes: Monitor and correct sodium and potassium abnormalities
  • Monitor blood pressure and cardiac function continuously

Important Clinical Nuances

Fludrocortisone is NOT required acutely when high-dose hydrocortisone is administered, as hydrocortisone at these doses provides sufficient mineralocorticoid activity 1. However, once the patient transitions to oral therapy and lower maintenance doses (30-50 mg/m²/24h), mineralocorticoid replacement with fludrocortisone 0.05-0.1 mg daily should be initiated 1.

The FDA labeling supports pediatric dosing of 0.56 to 8 mg/kg/day (20-240 mg/m²/day) in divided doses, which aligns with the guideline recommendations 3. In life-threatening situations, the FDA notes that doses exceeding usual dosages may be justified 3.

Transition to Oral Therapy

As clinical condition improves, transition to oral hydrocortisone at 30-50 mg/m²/24h, then gradually reduce to maintenance levels (typically 10-15 mg/m²/day in 3-4 divided doses for chronic management) 1.

Common Pitfalls to Avoid

  1. Delaying treatment while waiting for laboratory confirmation: Adrenal crisis is a clinical diagnosis—do not wait for cortisol levels before treating 2
  2. Inadequate fluid resuscitation: Children in adrenal crisis are profoundly volume depleted and require aggressive fluid replacement beyond just steroid administration
  3. Using long-acting steroids initially: Hydrocortisone is preferred; if unavailable, prednisolone or methylprednisolone may be used as alternatives 2
  4. Forgetting glucose monitoring: Hypoglycemia is common and life-threatening in pediatric adrenal crisis
  5. Premature discontinuation: High-dose therapy should continue until clinical stability, typically 48-72 hours 3

Context for India

A 2025 Indian study revealed significant knowledge gaps among patients with adrenal insufficiency, with 13% unaware of adrenal crisis symptoms and 13% failing to increase glucocorticoid doses during illness 4. This underscores the critical importance of provider-initiated emergency management, as patient/family recognition may be unreliable. The standardized weight-based dosing protocol from international guidelines 1 is directly applicable to Indian clinical practice and should be implemented immediately upon clinical suspicion of adrenal crisis in a child presenting with shock.

References

2
Research

Treatment and Prevention of Adrenal Crisis and Family Education.

Journal of clinical research in pediatric endocrinology, 2025

Related Questions

What is the appropriate hydrocortisone dosing regimen for pediatric patients in shock suspected to be due to adrenal insufficiency or refractory septic shock?
What is the recommended hydrocortisone dosing regimen for a pregnant woman with adrenal insufficiency, including maintenance and stress doses throughout pregnancy?
How should a patient with primary adrenal insufficiency who sustained a minor head trauma and now presents with confusion, acute memory loss, vomiting, headache, and ear pain be managed emergently?
What alternative glucocorticoid regimen can replace hydrocortisone 10 mg in the morning and 5 mg at night with prednisolone 5 mg daily for adrenal insufficiency?
What oral glucocorticoid alternatives are safe in pregnancy to replace hydrocortisone tablets for cortisol replacement?
In a patient with rheumatoid arthritis and baseline iron‑deficiency anemia, is a ferritin level of 40.7 ng/mL (below 100 ng/mL) considered too low?
What is the Tanaka classification for incisional hernias?
What is the appropriate immediate management for a hemodynamically stable patient with a blood pressure of 200/110 mm Hg?
What cardiovascular risks are associated with celecoxib?
What is the appropriate evaluation and management for a 25‑year‑old woman with a copper intrauterine device who recently discontinued sertraline and is now experiencing frequent spotting while the IUD remains in place?
How should moderate arthritic changes of the symphysis pubis with marginal osteophyte formation be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.